Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation - Nature Medicine

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

In a study of two children with the metabolic condition D-2-hydroxyglutaric aciduria type II, the IDH2 inhibitor enasidenib had beneficial effects on cardiac and neurodevelopmental abnormalities.

We thank N. Garcia for initial care and discussions on the patients; M. David, L. Delestre, P. Dessen and D. Farabos for excellent technical assistance; A. Boutron and E. Lebigot for providing primary fibroblasts; P. Rustin , G. Pierron and R. J. Morscher for discussions; A. Paci and J.

The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.Present address: Auron Therapeutics, Cambridge, MA, USAThese authors contributed equally: Chris Ottolenghi, Stéphane De Botton.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 451. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

HIPAA is a misunderstood and inadequate tool for protecting medical data - Nature MedicinePatients, physicians, and hospital administrators in the USA are often unaware of how legislation governs medical data—but agree that rights over such data should be expanded for patients and curtailed for health systems
Source: NatureMedicine - 🏆 451. / 53 Read more »

Lessons learned from translating AI from development to deployment in healthcare - Nature MedicineThe application of an artificial intelligence (AI)-based screening tool for retinal disease in India and Thailand highlighted the myths and reality of introducing medical AI, which may form a framework for subsequent tools
Source: NatureMedicine - 🏆 451. / 53 Read more »

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance - Nature MedicineA single-cell analysis of tumor-infiltrating T cells from 16 cancer types identifies new T cell subsets and a stress response cell state enriched in tumors resistant to immunotherapy.
Source: NatureMedicine - 🏆 451. / 53 Read more »

In global approaches to dementia research, do not forget care - Nature MedicineIn global approaches to dementia research, do not forget care. Correspondence from fannymonnet and colleagues VUBrussel ugent
Source: NatureMedicine - 🏆 451. / 53 Read more »

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease - Nature MedicineCross-sectional and longitudinal analyses of tau pathology in preclinical Alzheimer’s disease reveal that tau tangles accumulate as a function of amyloid-β burden only in individuals positive for an astrocyte reactivity biomarker.
Source: NatureMedicine - 🏆 451. / 53 Read more »

Giorgio Armani Explains How He Left Medicine to Become a Designer in His New AutobiographyDiscover the man behind the fashion empire. Giorgio Armani's new autobiography, 'Per Amore', unveils the untold stories and memories that shaped his extraordinary career.
Source: RobbReport - 🏆 309. / 63 Read more »